Search

Your search keyword '"Brian Bressler"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Brian Bressler" Remove constraint Author: "Brian Bressler" Topic humans Remove constraint Topic: humans
99 results on '"Brian Bressler"'

Search Results

1. Ustekinumab Therapeutic Drug Monitoring—Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial

2. A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities

3. Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

4. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey

5. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

6. Pharmacological inhibition of RORC2 enhances human Th17‐Treg stability and function

7. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease

8. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells

9. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study

11. Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?

12. Innate Control of Tissue-Reparative Human Regulatory T Cells

13. IBDoc Canadian User Performance Evaluation

14. Interleukin-37 regulates innate immune signaling in human and mouse colonic organoids

15. Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

16. Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

17. Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1

18. Enteroids Derived From Inflammatory Bowel Disease Patients Display Dysregulated Endoplasmic Reticulum Stress Pathways, Leading to Differential Inflammatory Responses and Dendritic Cell Maturation

19. Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives

20. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease

21. Prospective Comparison of Standard- Versus Low-Radiation-Dose CT Enterography for the Quantitative Assessment of Crohn Disease

22. PTG-100, an Oral α4β7 Antagonist Peptide

23. Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All

24. Appropriateness of Testing for Anti–Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

25. Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease

26. The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience

27. Vedolizumab for the treatment of ulcerative colitis

28. Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

29. Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates

30. Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis

31. Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

32. Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease

33. Comment on 'Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease'

34. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

35. Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease

36. Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease

37. Canadian Association of General Surgeons, the American College of Surgeons, the Canadian Society of Colorectal Surgeons and the American Society of Colorectal Surgeons Evidence Based Reviews in Surgery – Colorectal Surgery

38. Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada

39. A Survey of Perceptions and Practices of Complementary Alternative Medicine among Canadian Gastroenterologists

40. Safety and Efficacy of Hemospray®in Upper Gastrointestinal Bleeding

41. Editorial: aminosalicylates and nephrotoxicity-an issue put to rest

42. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

43. Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents

44. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease

45. Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: 'Which One Is the Best for What?'

46. Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

47. Author response

48. Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype

49. Performance of interferon-gamma release assays in patients with inflammatory bowel disease: A systematic review and meta-analysis

50. Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; A Comparative-Safety Study

Catalog

Books, media, physical & digital resources